Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no legitimate dupe for Wegovy. Semaglutide is a prescription-only medicine licensed in the UK for weight management, and no over-the-counter alternative, supplement or imitation product replicates what it does in the body. If you've landed here hoping to find something cheaper that works the same way, that's a completely understandable place to be — and this page will explain what actually exists, what doesn't, and why the shortcut you're looking for carries real risks. Wegovy (semaglutide) works by activating GLP-1 receptors to reduce appetite and slow gastric emptying; there is nothing you can buy freely that does the same thing lawfully in the UK. The medicines that genuinely help are prescription-only for good reason, and a free consultation with a prescriber is how legitimate access starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth correcting first, because it's everywhere on social media. People searching for a "Wegovy dupe" are usually hoping to find a supplement, a cheaper branded alternative, or an online seller offering semaglutide at a fraction of the NHS or private price. None of those routes deliver what they promise.
Supplements that claim to suppress appetite (glucomannan, green tea extract, various branded "fat burner" blends) have at best modest, inconsistent evidence behind them. None activates the GLP-1 receptor. None slows gastric emptying in the way semaglutide does. The clinical trial results that made Wegovy significant (roughly 15% average body-weight reduction over 68 weeks in the STEP 1 study published in the New England Journal of Medicine) were achieved through a specific pharmacological mechanism that supplements cannot replicate. The word "dupe" implies a functional equivalent exists. It doesn't.
The other version of the search involves sellers on social platforms or unfamiliar websites offering semaglutide pens at very low prices, sometimes with discount codes attached, sometimes with no clinical assessment mentioned at all. These are not a cheaper route to the same medicine. They are a route to either an ineffective product or a counterfeit one, and the MHRA's enforcement activity through 2024 and 2025 confirmed how large that market has become, with approximately 20 million doses of illegally traded weight-loss medicines (~£45m street value) seized in that period alone.
The MHRA has been direct on this. Counterfeit pens seized in the UK have contained the wrong substance entirely; some have contained insulin, which in a person without diabetes can cause life-threatening hypoglycaemia. A pen that looks identical to a genuine Wegovy device on the outside may contain nothing useful or something actively dangerous. The agency's guidance is consistent: only obtain these medicines through a pharmacy you can verify on the GPhC register.
There's another layer to the risk that's easy to miss. Even if a seller's product were genuine semaglutide, obtaining it without a proper clinical assessment means nobody has checked whether it's safe for you. Wegovy is not recommended during pregnancy, for anyone under 18, or for people with certain personal or family histories. Those safeguards exist in a clinical consultation. They don't exist when you buy from an unverified source.
Sellers offering a prescription medicine without a clinical assessment are operating outside UK law. That isn't a technicality, it's the mechanism that keeps patients safe. Reporting suspect sellers to the MHRA via the Yellow Card scheme is open to anyone, and it matters.
There are two licensed injectable options for weight management in the UK: Wegovy (semaglutide) and Mounjaro (tirzepatide). A third option (oral semaglutide in tablet form) received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. All three are prescription-only medicines. None is available over the counter. None has a legitimate dupe.
Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above alongside a weight-related health condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. You can read more about semaglutide and how it works to understand the mechanism properly. The cost of private treatment is one of the things people reasonably want to understand before starting, and the Wegovy price page covers the UK private market context honestly, including what legitimate pricing typically includes and why headline figures can be misleading.
Access through the NHS is possible for some people, though criteria are strict and waiting lists in specialist services are long for many. Private treatment through a GPhC-registered pharmacy is the alternative for people who meet clinical criteria but don't want to wait or don't qualify under the current NHS thresholds. The clinical assessment comes first either way; the medicine follows from it. Our clinical team reviews every consultation personally before anything is prescribed.
The cost of licensed treatment is a real barrier for some people, and it's worth naming that plainly rather than glossing over it. Private Wegovy pricing in the UK has moved significantly, and if you want to understand the dose steps involved, the pages covering Wegovy 0.5 mg and Wegovy 2 mg explain where those doses sit within the treatment journey. What's worth understanding is that the cost of a legitimate private prescription includes clinical assessment, the medicine itself, and dispensing by a regulated pharmacy. When you see a price significantly below the market range, something in that bundle is missing, usually the clinical oversight, sometimes the medicine's authenticity.
If private treatment isn't currently within reach, it's worth checking whether you might qualify for NHS access. The eligibility criteria for Wegovy under NICE guidance and the NHS's current referral pathways are worth reading carefully. For people exploring all their options, the weight loss treatment overview covers both the injectable and oral routes currently available. A prescriber can talk through what fits your situation when you start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.